Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)

被引:0
|
作者
Jeroen J. A. van Kampen
David A. M. C. van de Vijver
Pieter L. A. Fraaij
Bart L. Haagmans
Mart M. Lamers
Nisreen Okba
Johannes P. C. van den Akker
Henrik Endeman
Diederik A. M. P. J. Gommers
Jan J. Cornelissen
Rogier A. S. Hoek
Menno M. van der Eerden
Dennis A. Hesselink
Herold J. Metselaar
Annelies Verbon
Jurriaan E. M. de Steenwinkel
Georgina I. Aron
Eric C. M. van Gorp
Sander van Boheemen
Jolanda C. Voermans
Charles A. B. Boucher
Richard Molenkamp
Marion P. G. Koopmans
Corine Geurtsvankessel
Annemiek A. van der Eijk
机构
[1] Erasmus MC,Department of Viroscience
[2] Subdivision Infectious Diseases and Immunology,Department of Pediatrics
[3] Erasmus MC - Sophia,Department of Intensive Care
[4] Erasmus MC,Department of Hematology
[5] Erasmus MC,Department of Pulmonary Medicine
[6] Erasmus MC,Department of Internal Medicine, Division of Nephrology and Transplantation
[7] Erasmus MC Transplant Institute,Department of Gastroenterology and Hepatology
[8] Erasmus MC,Department of Medical Microbiology and Infectious Diseases
[9] Erasmus MC,undefined
[10] Erasmus MC,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Key questions in COVID-19 are the duration and determinants of infectious virus shedding. Here, we report that infectious virus shedding is detected by virus cultures in 23 of the 129 patients (17.8%) hospitalized with COVID-19. The median duration of shedding infectious virus is 8 days post onset of symptoms (IQR 5–11) and drops below 5% after 15.2 days post onset of symptoms (95% confidence interval (CI) 13.4–17.2). Multivariate analyses identify viral loads above 7 log10 RNA copies/mL (odds ratio [OR] of 14.7 (CI 3.57-58.1; p < 0.001) as independently associated with isolation of infectious SARS-CoV-2 from the respiratory tract. A serum neutralizing antibody titre of at least 1:20 (OR of 0.01 (CI 0.003-0.08; p < 0.001) is independently associated with non-infectious SARS-CoV-2. We conclude that quantitative viral RNA load assays and serological assays could be used in test-based strategies to discontinue or de-escalate infection prevention and control precautions.
引用
收藏
相关论文
共 50 条
  • [1] Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)
    van Kampen, Jeroen J. A.
    van de Vijver, David A. M. C.
    Fraaij, Pieter L. A.
    Haagmans, Bart L.
    Lamers, Mart M.
    Okba, Nisreen
    van den Akker, Johannes P. C.
    Endeman, Henrik
    Gommers, Diederik A. M. P. J.
    Cornelissen, Jan J.
    Hoek, Rogier A. S.
    van der Eerden, Menno M.
    Hesselink, Dennis A.
    Metselaar, Herold J.
    Verbon, Annelies
    de Steenwinkel, Jurriaan E. M.
    Aron, Georgina I.
    van Gorp, Eric C. M.
    van Boheemen, Sander
    Voermans, Jolanda C.
    Boucher, Charles A. B.
    Molenkamp, Richard
    Koopmans, Marion P. G.
    Geurtsvankessel, Corine
    van der Eijk, Annemiek A.
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [2] Diabetes and coronavirus disease-2019 (COVID-19)
    Unnikrishnan, Ranjit
    Saboo, Banshi
    Kesavadev, Jothydev
    Deshpande, Neeta
    Aravind, Sosale Ramachandra
    Joshi, Shashank
    Anjana, Ranjit Mohan
    Hussain, Akhtar
    Mohan, Viswanathan
    JOURNAL OF DIABETOLOGY, 2020, 11 (02) : 52 - 56
  • [3] Variable duration of viral shedding in cancer patients with coronavirus disease 2019 (COVID-19)
    Babady, N. Esther
    Cohen, Bevin
    McClure, Tara
    Chow, Karin
    Caldararo, Mario
    Jani, Krupa
    McMillen, Tracy
    Taur, Ying
    Shah, Monika
    Robilotti, Elizabeth
    Aslam, Anoshe
    Kamboj, Mini
    INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2022, 43 (10): : 1413 - 1415
  • [4] A Review of Coronavirus Disease-2019 (COVID-19)
    Singhal, Tanu
    INDIAN JOURNAL OF PEDIATRICS, 2020, 87 (04): : 281 - 286
  • [5] Coronavirus Disease-2019 (COVID-19) and the Liver
    Elhence, Anshuman
    Vaishnav, Manas
    Biswas, Sagnik
    Chauhan, Ashish
    Anand, Abhinav
    Shalimar
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2021, 9 (02) : 247 - 255
  • [6] A Review of Coronavirus Disease-2019 (COVID-19)
    Tanu Singhal
    The Indian Journal of Pediatrics, 2020, 87 : 281 - 286
  • [7] Management of coronavirus disease-2019 (COVID-19) in patients with diabetes
    Bodhini, Dhanasekaran
    Mohan, Viswanathan
    JOURNAL OF DIABETOLOGY, 2020, 11 (03) : 125 - 125
  • [8] Skin, mucosa and nail findings in hospitalized pediatric patients with Coronavirus disease-2019 (COVID-19)
    Ozen, Tunc
    Kahraman, Filiz Cebeci
    Ocal, Sevliya
    Ovali, Husnu Fahri
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2023, 98 (02) : 208 - 215
  • [9] Hospitalized coronavirus disease-2019 (COVID-19) patients with gastrointestinal symptoms have improved survival to discharge
    Renelus, Benjamin D.
    Khoury, Neil
    Chandrasekaran, Karthik
    Bekele, Ezana
    Briggs, William M.
    Jamorabo, Daniel S.
    DIGESTIVE AND LIVER DISEASE, 2020, 52 (12) : 1403 - 1406
  • [10] Laboratory diagnosis of coronavirus disease-2019 (COVID-19)
    Li, Chenxi
    Zhao, Chengxue
    Bao, Jingfeng
    Tang, Bo
    Wang, Yunfeng
    Gu, Bing
    CLINICA CHIMICA ACTA, 2020, 510 : 35 - 46